6/1/2020Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting ...

6/1/2020Chinese Antitrust Authority Imposes Maximum Fine In Rare Abuse Of Coll...

6/1/2020AbbVie and Jacobio Pharma Enter Parternership for Anticancer SHP2 Inhi...

6/1/2020Junshi Biosciences, Merck Partner on SCCHN Combo Therapy

6/1/2020Despite Stormy Days Ahead, Pockets of Hope and Opportunity Remain

6/1/2020CDE Solicits Comments on Two Draft Documents for Phase I Clinical Tria...

6/1/2020EMA Accepts First Application for Chinese-made Biosimilar HLX02

5/29/2020NMPA Issues List of Reference Formulations for Generic Drug Equivalenc...

5/29/2020Recent Executive Moves

5/29/2020Financial-related Company News in Brief

5/28/2020Challenges Posed to Chinese Biotechs in Post-Pandemic Era

5/28/2020New Report: China Pharmaceutical Distribution Industry Report to 2026

5/28/2020SMEI Bluebook 2020: Chinese Retail Pharmacy Market (Offline and Online...

5/28/2020SMEI Bluebook 2020: Urban and County Level Public Hospital Drug Market...

5/28/2020CDE Publishes Draft Clinical Research Design Guidelines for Liraglutid...

5/26/2020Sino Biopharma and Akeso Files NDA for Penpulimab in China

5/26/2020CFDI Solicits Comments on Two Draft Rules for Drug Registration Onsite...

5/26/2020Considerations on the Protection of Remdesivir under Trademark Law

5/26/2020CDE Seeks Comments on Draft ICH Guideline M9

5/26/2020NPC to Prioritize Legislation on Public Health in 2020

5/26/2020China-based Burning Rock Biotech files for U.S. IPO

5/26/2020Chi-Med and BeiGene Partners to Evaluate Combos of Surufatinib and Fru...

5/25/2020Alvogen Korea To Market Luye Pharma's Schizophrenia Treatment

5/25/2020Healthcare-related Highlights: Premier Li Delivers 2020 Government Wor...

5/25/2020NH Reports 5% Growth for 2019 OTC Gastrointestinal Market in China

5/25/2020Recent Executive Moves

5/22/2020Data Snapshot and Outlook of the Chinese Chronic Disease Market

5/22/2020CDE Solicits Public Comments on Technical Guidelines for Communication...

5/22/2020Apollomics Announces Initiation of SPARTA P2 Trial for c-MET Inhibitor...

5/22/2020Affibody Signs EUR208M Deal To Market Autoimmune Drug in China

Page:235/774 Total number of articles:23207: [First][<<] [233] [234] [235] [236] [237] [>>] [End]